Compare CWK & MMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CWK | MMS |
|---|---|---|
| Founded | 1784 | 1975 |
| Country | United States | United States |
| Employees | 53000 | N/A |
| Industry | Real Estate | Business Services |
| Sector | Finance | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 3.2B |
| IPO Year | 2018 | 1997 |
| Metric | CWK | MMS |
|---|---|---|
| Price | $12.91 | $56.48 |
| Analyst Decision | Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $17.64 | N/A |
| AVG Volume (30 Days) | ★ 1.6M | 444.0K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 2.02% |
| EPS Growth | N/A | ★ 10.42 |
| EPS | 0.17 | ★ 5.45 |
| Revenue | ★ $10,288,200,000.00 | $2,392,236,000.00 |
| Revenue This Year | $6.87 | $0.44 |
| Revenue Next Year | $5.98 | $5.15 |
| P/E Ratio | $77.47 | ★ $10.30 |
| Revenue Growth | ★ 8.91 | N/A |
| 52 Week Low | $11.57 | $52.73 |
| 52 Week High | $17.40 | $100.00 |
| Indicator | CWK | MMS |
|---|---|---|
| Relative Strength Index (RSI) | 37.35 | 43.81 |
| Support Level | $11.84 | $56.33 |
| Resistance Level | $12.93 | $60.74 |
| Average True Range (ATR) | 0.49 | 1.33 |
| MACD | -0.18 | -0.18 |
| Stochastic Oscillator | 2.33 | 20.00 |
Cushman & Wakefield is one of the largest commercial real estate services firms in the world and is headquartered in Chicago. The firm provides a broad suite of real estate-related services to owners, tenants, and investors. These include brokerage services for leasing and capital markets sales as well as advisory services such as valuation, project management, and facilities management.
Maximus Inc designs, develops, and delivers programs enabling people to access vital government services. It translates health and human services public policy into operating models that achieve outcomes for governments at scale. The company covers a broad array of services, including the operation of large health insurance eligibility and enrollment programs; clinical services, including assessments, appeals, and independent medical reviews; and technology services. The company operates through the following segments: U.S. Federal Services, U.S. Services, and Outside the U.S. A majority of its revenue is derived from the U.S. Federal Services segment, which engages with various U.S. federal government agencies to deliver clinical services, maintenance services, and technology solutions.